QNR
TW EN

scroll

Go Top

EMO Biomedicine was founded in 2004.  EMO is the first contract research organization (CRO) that focuses on cell-based assay and therapeutic cell-based product in Taiwan. EMO is one of the qualified CRO for pharmaceuticals by Ministry of Economic Affairs, Taiwan.

EMO’s Testing Lab is in compliance with ISO/IEC 17025 and accredited by Taiwan Accreditation Foundation (TAF) and TFDA. The accredited testing scope includes cell-based products, cell culture supernatant, and whole blood. 

EMO’s manufacturing facility and quality management systems for therapeutic cell-based product has been inspected by TFDA for the compliance of Good Tissue Practice (GTP) guidance. In December 2019, EMO’s Cell Processing Unit (CPU) received the certificate of manufacturing MSC-based product from TFDA. EMO is able to offer a complete service, including manufacturing and comprehensive testing, for local and oversea clients.
 

  • 01

    Biological characterization for biological products

  • 02

    Human specimen analysis for Clinical/preclinical study

  • 03

    Safety, characterization, and potency assays for therapeutic cell-based products

  • 04

    Assay development and validation/Immunoassay, cell-based bioassay, flow cytometry-based assay

  • 05

    Human cell/tissue processing, expansion, characterization, and banking

  • 06

    Manufacturing of therapeutic cell-based products

  • 07

    Clinical/preclinical study for cell therapy